JP2023550840A5 - - Google Patents
Info
- Publication number
- JP2023550840A5 JP2023550840A5 JP2023532331A JP2023532331A JP2023550840A5 JP 2023550840 A5 JP2023550840 A5 JP 2023550840A5 JP 2023532331 A JP2023532331 A JP 2023532331A JP 2023532331 A JP2023532331 A JP 2023532331A JP 2023550840 A5 JP2023550840 A5 JP 2023550840A5
- Authority
- JP
- Japan
- Prior art keywords
- quinazoline
- fluorophenyl
- alkyl
- methyl
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20210189 | 2020-11-27 | ||
| EP20210189.5 | 2020-11-27 | ||
| PCT/EP2021/083141 WO2022112490A1 (en) | 2020-11-27 | 2021-11-26 | Amino quinazoline derivatives as p2x3 inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023550840A JP2023550840A (ja) | 2023-12-05 |
| JP2023550840A5 true JP2023550840A5 (enExample) | 2024-11-29 |
| JP7844468B2 JP7844468B2 (ja) | 2026-04-13 |
Family
ID=73642588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023532331A Active JP7844468B2 (ja) | 2020-11-27 | 2021-11-26 | Ｐ２ｘ３阻害剤としてのアミノキナゾリン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240025880A1 (enExample) |
| EP (1) | EP4251620B1 (enExample) |
| JP (1) | JP7844468B2 (enExample) |
| KR (1) | KR20230113309A (enExample) |
| CN (1) | CN116601149A (enExample) |
| AU (1) | AU2021388923A1 (enExample) |
| CA (1) | CA3196333A1 (enExample) |
| ES (1) | ES3026309T3 (enExample) |
| MX (1) | MX2023005803A (enExample) |
| WO (1) | WO2022112490A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR132737A1 (es) | 2023-05-22 | 2025-07-23 | Chiesi Farm Spa | Proceso e intermedios para la preparación de un inhibidor p2x3 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2038264B1 (en) | 2006-06-29 | 2016-10-26 | F.Hoffmann-La Roche Ag | Tetrazole-substituted arylamides |
| EP2136639B1 (en) | 2007-04-02 | 2016-03-09 | Evotec AG | Pyrid-2-yl fused heterocyclic compounds, and compositions and uses thereof |
| PT2139334E (pt) | 2007-04-17 | 2013-10-02 | Evotec Ag | Compostos heterocíclicos fusionados de 2-cianofenilo, e composições e utilizações dos mesmos |
| CA2715835C (en) | 2008-02-29 | 2017-03-21 | Renovis, Inc. | Amide compounds, compositions and uses thereof |
| JP5608655B2 (ja) | 2008-09-18 | 2014-10-15 | エヴォテック アーゲー | Ｐ２ｘ３受容体活性のモジュレーター |
| JPWO2016084922A1 (ja) | 2014-11-28 | 2017-09-07 | 塩野義製薬株式会社 | １，２，４−トリアジン誘導体およびその医薬組成物 |
| WO2016088838A1 (ja) | 2014-12-04 | 2016-06-09 | 塩野義製薬株式会社 | プリン誘導体およびその医薬組成物 |
| EP3230281B1 (en) | 2014-12-09 | 2021-05-26 | Bayer Aktiengesellschaft | 1,3-thiazol-2-yl substituted benzamides |
| WO2017011729A1 (en) | 2015-07-16 | 2017-01-19 | Patara Pharma, LLC | Combination therapies for the treatment of lung diseases |
| DK3355889T3 (da) | 2015-09-29 | 2023-05-15 | Afferent Pharmaceuticals Inc | Diaminopyrimidin-p2x3- og p2x2/3-receptormodulatorer til anvendelse i behandling af hoste |
| CA3139018A1 (en) * | 2019-05-31 | 2020-12-03 | Chiesi Farmaceutici S.P.A. | Amino quinazoline derivatives as p2x3 inhibitors |
-
2021
- 2021-11-26 WO PCT/EP2021/083141 patent/WO2022112490A1/en not_active Ceased
- 2021-11-26 EP EP21811098.9A patent/EP4251620B1/en active Active
- 2021-11-26 AU AU2021388923A patent/AU2021388923A1/en active Pending
- 2021-11-26 CN CN202180079588.2A patent/CN116601149A/zh active Pending
- 2021-11-26 MX MX2023005803A patent/MX2023005803A/es unknown
- 2021-11-26 KR KR1020237018300A patent/KR20230113309A/ko active Pending
- 2021-11-26 CA CA3196333A patent/CA3196333A1/en active Pending
- 2021-11-26 ES ES21811098T patent/ES3026309T3/es active Active
- 2021-11-26 US US18/038,744 patent/US20240025880A1/en active Pending
- 2021-11-26 JP JP2023532331A patent/JP7844468B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7767492B2 (ja) | Ｇｌｐ－１受容体アゴニスト作用を持つピラゾロピリジン誘導体を含有する医薬組成物 | |
| JP3927175B2 (ja) | Ｎ−置換ヒドロキシピリミジノンカルボキサミド系ｈｉｖインテグラーゼ阻害薬 | |
| US5753666A (en) | Quinolones and their therapeutic use | |
| AU2012312305B2 (en) | Acyclic cyanoethylpyrazoles as janus kinase inhibitors | |
| CA2753434C (en) | Soluble guanylate cyclase activators | |
| JP5992615B2 (ja) | 抗癌剤であるシクロプロパンカルボキサミドで置換された芳香族化合物 | |
| JP7013467B2 (ja) | ウイルス感染の治療又は予防用の７位置換スルホンイミドイルプリノン化合物 | |
| CA2602738C (en) | Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof | |
| TW202246232A (zh) | Ｔｙｋ２抑制劑及其用途 | |
| JP4540337B2 (ja) | 新規４−アミノフロピリミジン化合物およびそれらの使用 | |
| JP2019510003A (ja) | ＪＡＫ阻害剤としてのピラゾロ［１，５−ａ］ピラジン−４−イル誘導体 | |
| JP2021505684A (ja) | ヒストンデアセチラーゼ６阻害剤としての１，２，４−オキサジアゾール誘導体 | |
| JP2006502119A (ja) | 新規２，５−二置換ピリミジン誘導体 | |
| JP2005537274A (ja) | ４−アミノ置換ピリミジン誘導体 | |
| TW200845998A (en) | Heterocyclic compounds useful in treating diseases and conditions | |
| JP2022502444A (ja) | ３−アザビシクロ［３，１，１］ヘプタン誘導体及びこれを含む薬学的組成物 | |
| KR20090023731A (ko) | 6-(헤테로사이클-치환 벤질)-4-옥소퀴놀린 화합물 및 ｈｉｖ 인테그라아제 억제제로서의 그의 용도 | |
| JP5411867B2 (ja) | 新規ｓＥＨ阻害剤およびそれらの使用 | |
| AU2019353144A1 (en) | Compounds and compositions for treating conditions associated with APJ receptor activity | |
| US11744824B2 (en) | 2-amino-3-carbonyl imidazopyridine and pyrazolopyridine compounds | |
| TW202504604A (zh) | 小分子前列腺素ｆ受體拮抗劑 | |
| ES2231439T3 (es) | Derivados benzooxazol como inhibidores de tnf y de pde iv. | |
| JP2006503854A (ja) | 新規モルホリン架橋インダゾール誘導体 | |
| JP2023550840A5 (enExample) | ||
| MX2007015705A (es) | Derivados biciclicos como inhibidores de la cinasa p38. |